Patients who have had a stroke are prescribed medication to prevent new strokes. Nevertheless, fewer than half achieve the optimal treatment targets.

Scientists from Monash University are partnering with colleagues at the Yale School of Medicine in New Haven, Conn., to ...

Ischemic heart disease, neoplasms, and cerebrovascular diseases emerged as the leading causes of death in the Philippines ...

Topline data show the Factor XIa inhibitor asundexian lowers recurrent stroke risk vs placebo with no increase in major bleeding events.

Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...

Stroke and heart attack are life-threatening conditions that require emergency medical attention, but they differ in the affected organ and symptoms.

New artificial intelligence (AI) technology available at qathet General Hospital (qGH) is helping hospital teams rapidly ...

Donald Glover, pictured in 2019, suffered a stroke while on tour in 2024. Credit - Gregg DeGuire—FilmMagic via Donald Glover ...

The research, development and innovation (RD&I) activities at the Johnson & Johnson MedTech Galway site are being expanded, the company has announced. The Galway site has been described as a hub for ...

Argenica Therapeutics has taken a step forward in the development of its neuroprotective drug candidate ARG-007 in acute ...

Johnson & Johnson MedTech is expanding its stroke-focused R&D in Ireland, building on previous investments and coming on the ...

Cerebrovascular diseases continue to represent a major global health challenge, with stroke among the leading causes of death ...